SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Discussion centers on BioCrysts weak share performance despite ORLADEYO revenue growth, with traders watching quarterly results for evidence that commercial momentum is holding. Sentiment is divided: some point to the companys valuation and future navenibart and Netherton data, while others criticize managements spending and acquisition strategy and worry about HAE competition.

XPeng, Inc. is a global physical AI company, which engages in bringing artificial intelligence into the physical world to reshape future mobility and smart living. It developed a full-stack physical AI architecture spanning Turing AI chips, world foundation models, and integrated software and hardware applications. The firm's product portfolio includes smart EVs, robotaxis, and humanoid robots. The company's sales and services drives continuous technological innovation and fosters an open physical AI ecosystem, making life smarter, safer, and better for users worldwide. XPeng, Inc. was founded by Xiao Peng He, Heng Xia, and Tao He in 2015 and is headquartered in Guangzhou, China.

XPeng Inc - ADR

XPengs record October deliveries and expanding overseas sales are drawing attention, with traders watching whether the company can sustain the pace needed to meet its fourth-quarter goals. The reaction is mixed: bulls point to export growth and rising volumes, while skeptics question whether growth can overcome tough competition and weak per-vehicle profitability.

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. Schimmel, and Phillip Allen Sharp on June 14, 2002, and is headquartered in Cambridge, MA.

Alnylam Pharmaceuticals Inc

Alnylams post-earnings selloff is drawing attention after traders focused on slower expected Amvuttra demand growth and guidance concerns, despite strong product sales and an earnings beat that included a large noncash tax benefit. The community is divided between investors watching support for a rebound and critics concerned about execution, access and pipeline delays.

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

Reports of substantial layoffs in India, with additional cuts in the Philippines, have raised concern that a client assignment was scaled back or a major customer may be reducing work; Innodata has not confirmed the scale or client involved. Traders are split between viewing the selloff as an overreaction or a potential sign of weaker demand, and many are waiting for the Q3 report to clarify the situation.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Discussion centers on CADLs planned Q4 BLA submission for CAN-2409 in localized prostate cancer and upcoming clinical-data presentations, including at SITC. Optimism about the Phase 3 results and pipeline is offset by frustration over the share-price decline, with traders debating macro biotech weakness, CEO share sales, possible dilution, and whether the filing will stay on schedule.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

FDA approval of Inovios competing RRP treatment has renewed concerns about competition for Precigens PAPZIMEOS. Traders debate the threat, weighing Inovios potential treatment advantages against Precigens commercial head start and full approval, while questioning the rivals reimbursement and launch prospects.

StoneCo Ltd. engages in the provision of financial technology solutions. It caters to merchants and partners that conduct electronic commerce across in-store, online, and mobile channels. The firm offers cloud-based technology platform, electronic payments, and automation of business processes at the point-of-sale. The company was founded by André Street de Aguiar in 2000 and is headquartered in São Paulo, Brazil.

StoneCo Ltd - Ordinary Shares - Class A

StoneCo Ltd

A sharp selloff in Brazilian equities following Brazils election results is driving attention to STNE, with traders debating whether the decline is an overreaction or reflects renewed political and macroeconomic risk. Some see the pullback as a buying opportunity given StoneCos valuation and buybacks, while others cite Brazil exposure and credit concerns as reasons for caution.

ProShares Trust - ProShares UltraPro QQQ 3x Shares

ProShares UltraPro QQQ

A sharp Nasdaq and tech-sector selloff, amid concerns about AI spending and market volatility, has weighed heavily on the leveraged TQQQ ETF. Traders are split between buying what they see as an oversold dip and warning that further declines may follow.

BNB (BNB) is a cryptocurrency . BNB has a current supply of 131,511,348.93. The last known price of BNB is 702.2705794 USD and is down -0.19 over the last 24 hours. It is currently trading on 3523 active market(s) with $1,103,086,320.06 traded over the last 24 hours. More information can be found at https://bnbchain.org/en.

Binance

A reported major Binance security breach and temporary withdrawal suspensions dominate discussion, with traders questioning the exchanges security and solvency and urging users to withdraw funds. Others argue Binance can cover the losses and view the market reaction as limited, while speculation about the breachs cause remains unconfirmed.

ProShares Trust II - ProShares Ultra Bloomberg Crude Oil 2x Shares

ProShares Ultra Bloomberg Crude Oil

UCO is drawing attention as traders react to the U.S.-Iran conflict and Strait of Hormuz shipping risks, which have fueled sharp swings in crude prices. Bulls see supply disruption as supportive, while bears expect a pullback if diplomacy eases tensions or supply concerns fade; some also criticize the funds leveraged performance in volatile trading.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


duakhan

Dua khan